0001209191-23-045641.txt : 20230814
0001209191-23-045641.hdr.sgml : 20230814
20230814163221
ACCESSION NUMBER: 0001209191-23-045641
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220729
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mohideen Pharis
CENTRAL INDEX KEY: 0001760395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36697
FILM NUMBER: 231171095
MAIL ADDRESS:
STREET 1: C/O OVASCIENCE, INC.
STREET 2: 9 FOURTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DBV Technologies S.A.
CENTRAL INDEX KEY: 0001613780
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: I0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 177-181 AVENUE PIERRE BROSSOLETTE
CITY: MONTROUGE
STATE: I0
ZIP: 92120
BUSINESS PHONE: 33(0)155427878
MAIL ADDRESS:
STREET 1: 177-181 AVENUE PIERRE BROSSOLETTE
CITY: MONTROUGE
STATE: I0
ZIP: 92120
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2022-07-29
0
0001613780
DBV Technologies S.A.
DBVT
0001760395
Mohideen Pharis
C/O DBV TECHNOLOGIES S.A.
177-181 AVENUE PIERRE BROSSOLETTE
MONTROUGE
I0
92120
FRANCE
0
1
0
0
Chief Medical Officer
0
Ordinary Shares
2022-07-29
4
A
0
10000
0.00
A
34200
D
Ordinary Shares
2022-11-21
4
A
0
17500
0.00
A
51700
D
Ordinary Shares
2022-11-24
4
S
0
1792
2.88
D
49908
D
Ordinary Shares
2023-05-24
4
S
0
469
3.54
D
49439
D
Employee Stock Option (right to buy)
4.83
2022-07-29
4
A
0
100000
0.00
A
2032-07-29
Ordinary Shares
100000
100000
D
Employee Stock Option (right to buy)
3.07
2022-11-21
4
A
0
115000
0.00
A
2032-11-21
Ordinary Shares
115000
115000
D
The ordinary shares may be represented by American Depositary Shares, each of which currently represents one-half of one ordinary share.
Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on July 29, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
Represents the Issuer's ordinary shares underlying a restricted stock unit RSU award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
Shares sold to satisfy withholding tax obligations upon the the vesting of RSUs.
This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0409 to EURO 1.00 as of November 24, 2022.
This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0746 to EURO 1.00 as of May 24, 2023.
This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0226 to EURO 1.00 as of July 29, 2022.
25% of the shares subject to the option vest on July 29, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0242 to EURO 1.00 as of November 21, 2022.
25% of the shares subject to the option vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
/s/ Jason Minio, Attorney-in-Fact
2023-08-14